Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2022-07-28+34,000→ 217,666 total - Award
Common Stock
2022-07-28+84,000→ 301,666 total
Footnotes (2)
- [F1]Represents Common Stock granted by the Issuer that vested on August 1, 2022.
- [F2]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 28,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.